Skip to main content

Advertisement

Table 1 Clinical characteristics of Parkinson’s disease patients

From: Sleep disturbances and gastrointestinal dysfunction are associated with thalamic atrophy in Parkinson’s disease

  PD patients
No (M, %) 41 (24, 58.5%)
Age (years; median ± SD) 65.0 ± 9.3
Disease durationa (months; median ± SD) 84.0 ± 71.8
Daily LED (mg; median ± SD) 480.0 ± 957.7
H&Y (median ± SD) 2.0 ± 1.0
NMSS (median ± SD) 37.0 ± 31.4
NMSS Domain 2: sleep/fatigue (median ± SD) 4.0 ± 7.7
NMS Domain 6: gastrointestinal tract (median ± SD) 3.0 ± 6.0
NMSQ (median ± SD) 8.0 ± 5.9
MMSE (median ± SD) 30.0 ± 1.3
PDQ-39 [(median ± SD) ± SD] 27.5 ± 24.4
  1. H&Y Hoein & Yahr, LED levodopa equivalent dose, MMSE mini mental status examination, NMSS Non-motor Symptoms Scale, NMSQ Non-motor Symptoms Questionnaire, PDQ-39 39-item Parkinson’s disease Questionnaire
  2. aFrom time of first appearance of Parkinson’s disease motor symptoms